Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | POLB | P06746 | 2/20 | 0.39 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.35 |
| ▸ | CA2 | P00918 | 2/20 | 0.35 |
| ▸ | ATM | Q13315 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.33 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.33 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL677702 | 0.84 | CA1 (0.34) | CA1CA2 | |
| SCHEMBL22616333 | 0.81 | LMNA (0.38) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL15200246 | 0.80 | KDM4E (0.42) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL24989267 | 0.79 | LMNA (0.37) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL15715425 | 0.79 | CA1 (0.36) | CA1CA2 | |
| SCHEMBL19457506 | 0.78 | MEN1 (0.41) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL1289956 | 0.77 | LMNA (0.40) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL20763636 | 0.77 | LMNA (0.36) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL17081346 | 0.77 | SMN1; SMN2 (0.37) | LMNAPOLBKDM4EL3MBTL1KMT2A | |
| SCHEMBL21764420 | 0.77 | LMNA (0.37) | LMNAPOLBKDM4EL3MBTL1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4676535-A1 | MULTI-ALBUMIN BINDING COMPOUNDS | Ascendis Pharma A/S (DK) | 2026-01-14 | — | — | EP | disclosed |
| WO-2024184354-A1 | MULTI-ALBUMIN BINDING COMPOUNDS | ASCENDIS PHARMA A/S (DK) | 2024-09-12 | — | — | WO | disclosed |
| US-20140087943-A1 | Pesticidal Active Mixtures Comprising Isoxazoline Compounds I | BASF SE (DE) | 2014-03-27 | — | — | US | disclosed |
| US-8563474-B2 | Pestcidal active mixtures comprising isoxazoline compounds I | BASF SE (DE) | 2013-10-22 | — | — | US | disclosed |
| US-20110159107-A1 | Pesticidal Mixtures Comprising Isoxazoline Compounds II | BASF SE (DE) | 2011-06-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110159107-A1 | Pesticidal Mixtures Comprising Isoxazoline Compounds II | PRDX1, PRDX2, PRDX5 | LMNA 3855/4885POLB 4374/4885KDM4E 3212/4885 |
| US-20140087943-A1 | Pesticidal Active Mixtures Comprising Isoxazoline Compounds I | CHRM3, CHRM5, CACNA1C | LMNA 3451/4885POLB 4675/4885KDM4E 2282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.